Verification evidence is still being completed.
BioResearch Pharma S.A.
Warsaw, Poland
- Verified lead
- Lukasz Zybaczynski
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Drug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs
- Review cycle
- 24 April 2026
- Full address
- ul. Zygmunta Glogera 2/11, 02-051 Warsaw, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- BioResearch Pharma company news naming Lukasz Zybaczynski as CEO and Co-founder.
- Editorial note
- Warsaw drug-repositioning biotech with named CEO, BioInMed cluster membership, and dermatology programs in alopecia and psoriasis.
Drug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs
Public CEO disclosure, BioInMed member recognition, BioForum 2024 keynote documentation
Warsaw drug-repositioning biotech with named CEO, BioInMed cluster membership, and dermatology programs in alopecia and psoriasis.
BioResearch Pharma S.A.
Drug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs · Drug-repositioning R&D
Warsaw drug-repositioning biotech with named CEO, BioInMed cluster membership, and dermatology programs in alopecia and psoriasis.
- Lead
- Lukasz Zybaczynski (verified ↗)
- Address
- ul. Zygmunta Glogera 2/11, 02-051 Warsaw, Poland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Drug-repositioning R&D
- Capabilities
- Drug Repositioning Pipeline · Dermatology Clinical Development · Clinical and Licensing Strategy
- Founded
- 2014
- Headcount
- 1-10
Lukasz Zybaczynski
Chief Executive Officer and Co-Founder
EMIS company profile listing BioResearch Pharma at Zygmunta Glogera 2/11 in Warsaw.
Open sourceDrug-repositioning R&D
Warsaw, Poland. Drug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs. Review completed on 24 Apr 2026.
Polish Office for Registration of Medicinal Products and EMA for future oversight
Public CEO disclosure, BioInMed member recognition, BioForum 2024 keynote documentation
Drug Repositioning, Dermatology, and Androgenetic Alopecia and Psoriasis Programs
Warsaw drug-repositioning biotech with named CEO, BioInMed cluster membership, and dermatology programs in alopecia and psoriasis.
BioResearch Pharma is a Warsaw drug-repositioning biotech with a named CEO and public BioForum keynote visibility, focused on dermatology programs for alopecia and psoriasis.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is BioResearch Pharma S.A. located?
- BioResearch Pharma S.A. operates from ul. Zygmunta Glogera 2/11, 02-051 Warsaw, Poland, Warsaw, Poland.
- Who runs BioResearch Pharma S.A.?
- BioResearch Pharma S.A. is led by Lukasz Zybaczynski, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What does BioResearch Pharma S.A. do?
- Warsaw drug-repositioning biotech with named CEO, BioInMed cluster membership, and dermatology programs in alopecia and psoriasis. Core capabilities: Drug Repositioning Pipeline, Dermatology Clinical Development, Clinical and Licensing Strategy.
Related technical briefs
Briefs that name Warsaw as a covered market or city.
